These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23953988)

  • 21. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
    Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
    Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) study.
    Husain AM
    Epilepsia; 2013 Sep; 54 Suppl 6():84-8. PubMed ID: 24001083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.
    Fattouch J; Di Bonaventura C; Casciato S; Bonini F; Petrucci S; Lapenta L; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2010 Jun; 121(6):418-21. PubMed ID: 20578996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous lacosamide for treatment of status epilepticus.
    Kellinghaus C; Berning S; Immisch I; Larch J; Rosenow F; Rossetti AO; Tilz C; Trinka E
    Acta Neurol Scand; 2011 Feb; 123(2):137-41. PubMed ID: 20868429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.
    Albers JM; Möddel G; Dittrich R; Steidl C; Suntrup S; Ringelstein EB; Dziewas R
    Seizure; 2011 Jun; 20(5):428-30. PubMed ID: 21354831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous lacosamide in status epilepticus: Correlation between loading dose, serum levels, and clinical response.
    Perrenoud M; André P; Alvarez V; Stähli C; Decosterd LA; Rossetti AO; Novy J
    Epilepsy Res; 2017 Sep; 135():38-42. PubMed ID: 28622537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lacosamide in status epilepticus: Update on the TRENdS study.
    Husain AM
    Epilepsy Behav; 2015 Aug; 49():337-9. PubMed ID: 26152818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
    Poddar K; Sharma R; Ng YT
    Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.
    Chen LL; Haneef Z; Dorsch A; Keselman I; Stern JM
    Seizure; 2011 Apr; 20(3):263-5. PubMed ID: 21109468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide.
    Shiloh-Malawsky Y; Fan Z; Greenwood R; Tennison M
    Seizure; 2011 Sep; 20(7):586-8. PubMed ID: 21474342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of lacosamide in the intensive care unit.
    Cherry S; Judd L; Muniz JC; Elzawahry H; LaRoche S
    Neurocrit Care; 2012 Apr; 16(2):294-8. PubMed ID: 22203547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide for the treatment of refractory status epilepticus.
    Fernandez EM; Franck AJ
    Ann Pharmacother; 2011 Nov; 45(11):1445-9. PubMed ID: 22010001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid loading of intravenous lacosamide: efficacy and practicability during presurgical video-EEG monitoring.
    Li W; Stefan H; Matzen J; Rampp S; Heinze HJ; Schmitt FC
    Epilepsia; 2013 Jan; 54(1):75-80. PubMed ID: 22998639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status epilepticus developing during lacosamide monotherapy.
    Papacostas SS
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25628098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus.
    LaRoche SM; Shivdat-Nanhoe R
    Seizure; 2011 Jul; 20(6):505-8. PubMed ID: 21459625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide in status epilepticus: Systematic review of current evidence.
    Strzelczyk A; Zöllner JP; Willems LM; Jost J; Paule E; Schubert-Bast S; Rosenow F; Bauer S
    Epilepsia; 2017 Jun; 58(6):933-950. PubMed ID: 28295226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.